tolterodine

Known as: (+)-Tolterodine, Tolterodinum, Tolterodina 
A benzhydryl compound and a muscarinic receptor antagonist possessing both antimuscarinic and antispasmodic properties. Both tolterodine and its… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2017
020406019952017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
OBJECTIVE To compare the efficacy and tolerability of fesoterodine 8 mg with tolterodine extended-release (ER) 4 mg and placebo… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE The Overactive Bladder Innovative Therapy trial was a randomized, multicenter, controlled study that compared the… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Some men receiving alpha-blocker therapy for lower urinary tract symptoms report persistent storage symptoms… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2006
Highly Cited
2006
CONTEXT Men with overactive bladder and other lower urinary tract symptoms may not respond to monotherapy with antimuscarinic… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To compare two new generation antimuscarinics at their recommended doses for treatment of overactive bladder syndrome… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
OBJECTIVE To assess in a phase 3a trial the efficacy of solifenacin succinate, a once-daily oral antimuscarinic agent in… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
OBJECTIVES To compare the efficacy and safety of an oxybutynin transdermal delivery system (OXY-TDS) and oral, long-acting… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVES To evaluate the efficacy and tolerability of a new extended-release (ER), once-daily, capsule formulation of… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To compare the efficacy and tolerability of tolterodine with that of oxybutynin in patients with an overactive bladder… (More)
Is this relevant?
1997
1997
Tolterodine is a new muscarinic receptor antagonist intended for the treatment of urinary urge incontinence and other symptoms… (More)
Is this relevant?